Sudan is a highly endemic area for hepatitis B virus (HBV),Hepatitis B virus (HBV) infection remains a major health problem causing considerable morbidity and mortality despite the availability of vaccine and antiviral treatments. The World Health Organization (WHO) estimates that more than onethird of the world population is or has been in contact with the virus, resulting in Ͼ350 million HBV chronic carriers worldwide, with Ͼ18% of them living in Africa. Sudan is classified among the African countries with high HBV endemicity. The reported prevalence of HBV chronic infection, characterized by the detectable level of HBV surface antigen (HBsAg), varied from region to region and ranged between 5 and 7% in the general population (1,13,28,31) and 26% in hospital outpatients (25). The prevalence of adults having been in contact with HBV and identified by the presence of anti-core antibodies (anti-HBc) was high, ranging between 47.5 and 67% (25,28).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.